Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.09 USD
Change Today +0.0089 / 11.54%
Volume 7.9K
AFFY On Other Exchanges
AFFY is not on other exchanges.
As of 8:10 PM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John A. Orwin

AgeTotal Calculated CompensationThis person is connected to 140 board members in 5 different organizations across 6 different industries.

See Board Relationships


Mr. John A. Orwin has been the Chief Executive Officer of Relypsa, Inc. since June 17, 2013 and has been its President since June 2013. Mr. Orwin is a biotechnology and pharmaceutical industry veteran with nearly 25 years of experience, including senior leadership positions in many commercial oncology organizations. He served as the Chief Executive Officer of Affymax, Inc. from February 1, 2011 to May 15, 2013. Mr. Orwin served as the President and Chief Operating Officer ...

Read Full Background

Corporate Headquarters*

19200 Stevens Creek Boulevard
Cupertino, California 95014

United States

Phone: 650-812-8700
Fax: --

Board Members Memberships*

Director, Chairman of Nominating & Governance Committee and Member of Audit Committee
Director, Chairman of Corporate Governance Committee, Member of Compensation Committee and Member of Clinical Development Committee
Chief Executive Officer, President and Director
Director and Member of Audit Committee


New York University - Leonard N. Stern School of Business
Rutgers, The State University of New Jersey

Other Affiliations*

Annual Compensation*

Total Annual Compensation$540,075

Stock Options*

Restricted Stock Awards$544,200
All Other Compensation$396
Exercisable Options831,432
Unexercisable Options94,500
Total Number of Options925,932

Total Compensation*

Total Annual Cash Compensation$787,371
Total Short Term Compensation$540,075
Other Long Term Compensation$544,596
Total Calculated Compensation$3,292,231
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AFFY:US $0.09 USD +0.0089


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AFFYMAX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at